US2009075369A1PendingUtilityA1

Angiostatin Fragments and Method of Use

Assignee: FOLKMAN M JUDAHPriority: Apr 26, 1994Filed: Oct 15, 2007Published: Mar 19, 2009
Est. expiryApr 26, 2014(expired)· nominal 20-yr term from priority
G01N 33/575C12N 9/6435C12Y 304/21007A61K 48/00A61K 38/00
58
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Fragments of an endothelial cell proliferation inhibitor and method of use therefor are provided. The endothelial proliferation inhibitor is a protein derived from plasminogen, or more specifically is an angiostatin fragment. The angiostatin fragments generally correspond to kringle structures occurring within the endothelial cell proliferation inhibitor. The endothelial cell inhibiting activity of these fragments provides a means for inhibiting angiogenesis of tumors and for treating angiogenic-mediated disease.

Claims

exact text as granted — not AI-modified
1 - 63 . (canceled) 
     
     
         64 . An isolated nucleic acid molecule consisting of a nucleotide sequence encoding a fragment of plasminogen,
 wherein the fragment of plasminogen consists of a kringle 2-3 fragment, a kringle 1-3 fragment, a kringle 1-2 fragment, a kringle 4 fragment, a kringle 1-4 fragment, or a kringle 1-4BKLS fragment.   
     
     
         65 . A vector comprising a nucleotide sequence encoding a fragment of plasminogen, wherein
 the fragment of plasminogen consists of a kringle 2-3 fragment, a kringle 1-3 fragment, a kringle 1-2 fragment, a kringle 4 fragment, a kringle 1-4 fragment, or a kringle 1-4BKLS fragment, and   when the vector is expressed, the fragment of plasminogen is produced.   
     
     
         66 . A method of modulating angiogenesis in an animal or a human comprising administering to the animal or the human a composition comprising a nucleotide sequence encoding a fragment of plasminogen, wherein
 the fragment of plasminogen consists of a kringle 2-3 fragment, a kringle 1-3 fragment, a kringle 1-2 fragment, a kringle 4 fragment, a kringle 1-4 fragment, or a kringle 1-4BKLS fragment, and   when the vector is expressed, the fragment of plasminogen is produced.

Join the waitlist — get patent alerts

Track US2009075369A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.